Literature DB >> 31237047

Ultrasound morphometric and cytologic preoperative assessment of inguinal lymph-node status in women with vulvar cancer: MorphoNode study.

G Garganese1,2, S M Fragomeni3, T Pasciuto4, M Leombroni3, F Moro3, M T Evangelista5, S Bove2, S Gentileschi6,7, L Tagliaferri8, I Paris3, F Inzani9, F Fanfani3,10, G Scambia3,10, A C Testa3,10.   

Abstract

OBJECTIVE: To assess the accuracy of preoperative ultrasound examination for predicting lymph-node (LN) status in patients with vulvar cancer.
METHODS: This was a single-institution retrospective observational study of all women with a histological diagnosis of vulvar cancer triaged to inguinal surgery within 30 days following ultrasound evaluation between December 2010 and January 2016. For each groin examined, 15 morphological and dimensional sonographic parameters associated with suspicion for LN involvement were examined. A morphometric ultrasound pattern (MUP) was expressed for each groin, classifying the inguinal LN status into five groups (normal; reactive-but-negative; minimally suspicious/probably negative; moderately suspicious; and highly suspicious/positive) according to subjective judgment, followed by stratification as positive or negative for metastasis according to morphometric binomial assessment (MBA). In cases of positive MBA, fine-needle aspiration cytology was performed. Combining the information obtained from MUP and cytologic results, a binomial final overall assessment (FOA) was assigned for each groin. The final histology was considered as the reference standard. Comparison was performed between patients with negative and those with positive LNs on histology, and receiver-operating-characteristics curves were generated for statistically significant variables on univariate analysis, to evaluate their diagnostic ability to predict negative LN status.
RESULTS: Of 144 patients included in the analysis, 87 had negative inguinal LNs and 57 had positive LNs on histology. A total of 256 groins were analyzed, of which 171 were negative and 85 showed at least one metastatic LN on histology. The following parameters showed the greatest accuracy, with the best balance between specificity and sensitivity, in predicting negative LN status: cortical (C) thickness of the dominant LN (cut-off, 2.5 mm; sensitivity, 90.0%; specificity, 77.9%); short-axis (S) length of the dominant LN (cut-off, 8.4 mm; sensitivity, 63.9%; specificity, 90.6%); C/medulla (M) thickness ratio of the dominant LN (cut-off, 1.2 mm; sensitivity, 70.4%; specificity, 91.5%), the combination of S length and C/M thickness ratio (sensitivity, 88.9%; specificity, 82.4%); and the FOA analysis (sensitivity, 85.9%; specificity, 84.2%).
CONCLUSIONS: Preoperative ultrasound assessment, with or without the addition of cytology, has a high accuracy in assessing inguinal LN status in patients with vulvar cancer. In particular, the combination of two ultrasound parameters (S length and C/M thickness ratio) provided the greatest accuracy in discriminating between negative and positive LNs.
Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  groin; lymph nodes; ultrasonography; vulvar neoplasms

Year:  2020        PMID: 31237047     DOI: 10.1002/uog.20378

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  8 in total

1.  VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients.

Authors:  Antonella Ravaggi; Angela Gambino; Federico Ferrari; Alessandro Olivari; Laura Zanotti; Chiara Romani; Laura Ardighieri; Paolo Antonelli; Giorgia Garganese; Daniela Gallo; Giovanni Scambia; Eliana Bignotti; Enrico Sartori; Stefano Calza; Franco Odicino
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

Review 2.  The Role of Ultrasound in the Evaluation of Inguinal Lymph Nodes in Patients with Vulvar Cancer: A Systematic Review and Meta-Analysis.

Authors:  Debora Verri; Francesca Moro; Simona Maria Fragomeni; Drieda Zaçe; Sonia Bove; Federica Pozzati; Benedetta Gui; Giovanni Scambia; Antonia Carla Testa; Giorgia Garganese
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

3.  Recommendations for the treatment of vulvar cancer in settings with limited resources: Report from the International Gynecological Cancer Society consensus meeting.

Authors:  Fernando Cotait Maluf; Graziela Dal Molin Zibetti; Eduardo Paulino; Andreia Cristina de Melo; Douglas Racy; Robson Ferrigno; Pedro Luiz Serrano Uson Junior; Reitan Ribeiro; Renato Moretti; Jose Carlos Sadalla; Angelica Nogueira Rodrigues; Filomena Marino Carvalho; Glauco Baiocchi; Donato Callegaro-Filho; Roberto Angioli
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

4.  Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT.

Authors:  Giorgia Garganese; Luca Tagliaferri; Simona Maria Fragomeni; Valentina Lancellotta; Giuseppe Colloca; Giacomo Corrado; Stefano Gentileschi; Gabriella Macchia; Enrica Tamburrini; Maria Antonietta Gambacorta; Anna Fagotti; Giovanni Scambia
Journal:  J Cancer Res Clin Oncol       Date:  2020-07-12       Impact factor: 4.553

5.  Comparison of two types of the triple incision technique in the treatment of patients with locally advanced vulvar cancer.

Authors:  Ying Ma; Wei-Feng Liang; Chang-Hao Liu; Zhong-Qiu Lin; Miao-Fang Wu; Jing Li
Journal:  Int J Med Sci       Date:  2020-09-16       Impact factor: 3.738

Review 6.  Building a Personalized Medicine Infrastructure for Gynecological Oncology Patients in a High-Volume Hospital.

Authors:  Nicolò Bizzarri; Camilla Nero; Francesca Sillano; Francesca Ciccarone; Marika D'Oria; Alfredo Cesario; Simona Maria Fragomeni; Antonia Carla Testa; Francesco Fanfani; Gabriella Ferrandina; Domenica Lorusso; Anna Fagotti; Giovanni Scambia
Journal:  J Pers Med       Date:  2021-12-21

7.  The Vulvar Immunohistochemical Panel (VIP) Project: Molecular Profiles of Vulvar Squamous Cell Carcinoma.

Authors:  Giorgia Garganese; Frediano Inzani; Simona Maria Fragomeni; Giulia Mantovani; Luigi Della Corte; Alessia Piermattei; Angela Santoro; Giuseppe Angelico; Luciano Giacò; Giacomo Corrado; Anna Fagotti; Gian Franco Zannoni; Giovanni Scambia
Journal:  Cancers (Basel)       Date:  2021-12-19       Impact factor: 6.639

8.  Diagnostic performance of preoperative [18F]FDG-PET/CT for lymph node staging in vulvar cancer: a large single-centre study.

Authors:  Vittoria Rufini; Giorgia Garganese; Francesco P Ieria; Tina Pasciuto; Simona M Fragomeni; Benedetta Gui; Anita Florit; Frediano Inzani; Gian Franco Zannoni; Giovanni Scambia; Alessandro Giordano; Angela Collarino
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-23       Impact factor: 9.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.